No Data
European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading
U.S. stocks are experiencing fluctuations | Novo-Nordisk A/S (NVO.US) is rising nearly 2% against the trend while developing weight-loss drugs using AI.
On Friday, Novo-Nordisk A/S (NVO.US) rose nearly 2% against the trend, closing at $86.77.
Novo Holdings Invests in $200M Series A for Windward Bio Launch to Advance Long-acting Treatments for Asthma and COPD
HIMS Downgraded, Agilon Upgraded at Citi in 2025 Health Tech Review
Novo Nordisk Still a Buy, But Patience May Be Needed -- Market Talk
Pharma Companies Welcome New Year With 583 Drug Price Hikes so Far
pootpoot : its consolidating i guess. with overall market index now being so nervous, i dont think it will breakout anytime soon.
Mimo803734 OP : not looking for a breakout but at least not loosing 2% worth of value....
pootpoot Mimo803734 OP : hourly i can see it heading towards 85.4. or daily 8ma 85.8. if both of fails to hold, its a retest of low or new lows.
Mimo803734 OP pootpoot : yes iagree